Home

ESSEX WOODLANDS HEALTH VENTURES FUND VII LP

CIK 1367998 · last filed 2018-11-29

ESSEX WOODLANDS HEALTH VENTURES FUND VII LP is a corporate insider who has filed 19 SEC Form 4 insider transactions across 3 companies since 2008. Across all open-market trades the lifetime net is −$29.8M, making them a net seller over the disclosed history. The firm reports its address in The Woodlands, TX. 3 SEC filings were submitted jointly with ABIOMED INC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

3

Total Filings

19

Lifetime Open-Market Net

-$29.79M

Filer Profile

Reported Address
21 WATERWAY AVENUE
SUITE 225
THE WOODLANDS, TX 77380
Phone
(281) 364-8338
Related Filers
ABIOMED INC — 3 joint filings, latest 2017-02-16
PHARMACEUTICAL CO LA JOLLA — 3 joint filings, latest 2009-08-07
ESSEX WOODLANDS HEALTH VENTURES FUND V LP — same reported address
ESSEX WOODLANDS HEALTH VENTURES FUND VI L P — same reported address
ESSEX WOODLANDS HEALTH VENTURES FUND VIII LP — same reported address
ESSEX WOODLANDS HEALTH VENTURES FUND VIII-A LP — same reported address
ESSEX WOODLANDS HEALTH VENTURES FUND VIII-B LP — same reported address
EW Healthcare Partners Fund 2 GP, L.P. — same reported address
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ENDOLOGIX INC /DE/ (ELGX) Delisted 10%+ Owner 116,543 — — -$56.83M 4 2012-11-05
Horizon Therapeutics Public Ltd Co (HZNP) Delisted 10%+ Owner 5,064,731 $116.30 $589.03M $12.88M 2 2012-03-05
LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted 10%+ Owner 8,752 $6.22 $54.4K $14.15M 3 2009-08-07

Recent Filings

19 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2018-11-29 — U −9,353,304 -$116.92M
2012-11-05 ENDOLOGIX INC /DE/ (ELGX) Delisted Sell (S) −1,250,000 -$16.46M EDGAR
2012-09-12 ENDOLOGIX INC /DE/ (ELGX) Delisted Sell (S) −461,892 -$5.61M EDGAR
2012-09-07 ENDOLOGIX INC /DE/ (ELGX) Delisted Sell (S) −1,538,108 -$18.67M EDGAR
2012-03-05 Horizon Therapeutics Public Ltd Co (HZNP) Delisted Mixed +2,761,477 $9.91M EDGAR
2012-02-29 ENDOLOGIX INC /DE/ (ELGX) Delisted Sell (S) −1,250,000 -$16.09M EDGAR
2011-08-04 Horizon Therapeutics Public Ltd Co (HZNP) Delisted Mixed +2,303,254 $6.23M EDGAR
2011-06-29 — U −9,633,139 -$37.09M
2009-08-07 LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted Sell (S) −1,060,619 -$196.8K EDGAR
2009-02-26 LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted Sell (S) −6,746,796 -$406.5K EDGAR
Showing 1–10 of 19
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.